It works whether you lose weight or not.
Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic benefit for patients with severe forms of treatment-resistant autoimmune ...
“Interestingly, BIRC5 and MCL-1 have both been reported to be over-expressed and strongly correlated with progression and ...
A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve ...
No, it’s not a fever dream. A deadly disease that toppled ancient civilizations is becoming increasingly resistant to antibiotics, posing a significant threat in certain parts of the world. “Despite ...
Dr. Coleman: For patients with recurrent ovarian cancer, the main benefit of adding Lifyorli to nab-paclitaxel is controlling ...
Researchers estimated that 87% of the total costs were linked to infections resistant to commonly prescribed medicines, ...
FDA authorization covers platinum-resistant disease after 1–3 prior lines, with mandatory prior bevacizumab exposure, ...
Holly Ahern, of Ballston Lake, New York, is a professor emerita of microbiology, a researcher working on improved diagnostic tests for Lyme disease, a member of state and federally convened working ...
Metabolic dysfunction may be more than a comorbidity in bipolar disorder—it could be a key driver of disease progression and ...